MedPath

PAI Holdings, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

45

FDA:45

Drug Approvals

Senna

Approval Date
Apr 28, 2025
FDA

Cefotan

Approval Date
Mar 22, 2024
FDA

Cetirizine Hydrochloride

Approval Date
Mar 20, 2024
FDA

Fluoxetine

Approval Date
Mar 19, 2024
FDA

Lidocaine Hydrochloride

Approval Date
Feb 20, 2024
FDA

Atovaquone

Approval Date
Feb 14, 2024
FDA

Promethazine with Codeine

Approval Date
Jan 30, 2024
FDA

Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide

Approval Date
Jan 24, 2024
FDA

Promethazine Hydrochloride

Approval Date
Jan 24, 2024
FDA

Promethazine VC with Codeine Oral Solution

Approval Date
Jan 22, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.